Identification of the novel N-phenylbenzenesulfonamide derivatives as potent HIV inhibitors

Chinese Chemical Letters

Volumn 26, Issue 2, 2015, Pages 243-247

  Sun, Yong ^a   Lu, Cui Lin ^b,c   Wang, Chang Yuan ^a   Wang, Rui Rui ^b   Liu, Ke Xin ^a   Yang, Liu Meng ^b   Zhen, Yu Hong ^a   Zhang, Hou Li ^a   Wang, Chao ^a   Zheng, Yong Tang ^b   Ma, Xiao Dong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Anti HIV activity; Benzophenone; N Phenylbenzenesulfonamide; Structure modification

Indexed keywords

EID: 84923859215     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2014.11.004     Document Type: Article

References (23)

1. W. Schaefer, W.G. Friebe, and H. Leinert Non-nucleoside inhibitors of HIV-1 reverse transcriptase: molecular modeling and X-ray structure investigations J. Med. Chem. 36 1993 726 732
2. J.F. Palella, K.M. Delaney, and A.C. Moorman Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators N. Engl. J. Med. 338 1998 853 860
3. E. De Clerck New developments in anti-HIV chemotherapy Curr. Med. Chem. 8 2001 1543 1572
4. M.P. de Béthune Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009) Antivir. Res. 85 2010 75 90
5. R.A. Koup, V.J. Merluzzi, and K.D. Hargrave Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587 J. Infect. Dis. 163 1991 966 970
6. W.W. Freimuth Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor Adv. Exp. Med. Biol. 394 1996 279 289
7. S.D. Young, S.F. Britcher, and L.O. Tran L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase Antimicrob. Agents Chemother. 39 1995 2602 2605
8. L.B. Johnson, and L.D. Saravolatz Etravirine, a next-generation nonnucleoside reverse-transcriptase inhibitor Clin. Infect. Dis. 48 2009 1123 1128
9. S. Moreno, J. López Aldeguer, and J.R. Arribas The future of antiretroviral therapy: challenges and needs J. Antimicrob. Chemother. 65 2010 827 835
10. H. Azijn, I. Tirry, and J. Vingerhoets TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1 Antimicrob. Agents Chemother. 54 2010 718 727
11. Z. Zhang, R. Hamatake, and Z. Hong Clinical utility of current NNRTIs and perspectives of new agents in this class under development Antivir. Chem. Chemother. 15 2004 121 134
12. Guidelines for the Use of Antiretro Iral Agents in HIV-1-Infected Adults and Adolescents. http://AIDSinfo.nih.gov (29.10.04).
13. R.M. Grant, F.M. Hecht, and M. Warmerdam Time trends in primary HIV-1 drug resistance among recently infected persons JAMA 288 2002 181 188
14. J.H. Chan, G.A. Freeman, and J.H. Tidwell Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1 J. Med. Chem. 47 2004 1175 1182
15. K.R. Romines, G.A. Freeman, and L.T. Schaller Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitor J. Med. Chem. 49 2006 727 739
16. R.G. Ferris, R.J. Hazen, and G.B. Roberts Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor Antimicrob. Agents Chemother. 49 2005 4046 4051
17. P.G. Wyatt, R.C. Bethell, and N. Cammack Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase J. Med. Chem. 38 1995 1657 1665
18. X.D. Ma, Q.Q. He, and X. Zhang Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors Eur. J. Med. Chem. 58 2012 504 512
19. X.D. Ma, X. Zhang, and H.F. Dai Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors Bioorg. Med. Chem. 19 2011 4601 4607
20. X.D. Ma, X. Zhang, and S.Q. Yang Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors Bioorg. Med. Chem. 19 2011 4704 4709
21. S.X. Gu, X. Zhang, and Q.Q. He Synthesis and biological evaluation of naphthyl phenyl ethers (NPEs) as novel nonnucleoside HIV-1 reverse transcriptase inhibitors Bioorg. Med. Chem. 19 2011 4220 4226
22. Y.T. Zheng, K.L. Ben, and S.W. Jin Anti-HIV-1 activity of trichobitacin, a novel ribosome-inactivating protein Acta Pharmacol. Sin. 21 2000 179 182
23. D.S. Goodsell, G.M. Morris, and A.J. Olson Automated docking of flexible ligands: applications of AutoDock J. Mol. Recognit. 9 1996 1 5